MedPath

YUSIMRY

These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY.YUSIMRY (adalimumab-aqvh) injection, for subcutaneous useInitial U.S. Approval: 2021

Approved
Approval ID

cd0e7af2-7704-49ce-bde9-f645294b6788

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 30, 2023

Manufacturers
FDA

Coherus BioSciences Inc

DUNS: 078502849

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

adalimumab-aqvh

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70114-210
Application NumberBLA761216
Product Classification
M
Marketing Category
C73585
G
Generic Name
adalimumab-aqvh
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateFebruary 28, 2023
FDA Product Classification

INGREDIENTS (7)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ADALIMUMABActive
Quantity: 40 mg in 0.8 mL
Code: FYS6T7F842
Classification: ACTIB
HISTIDINEInactive
Code: 4QD397987E
Classification: IACT
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATEInactive
Code: X573657P6P
Classification: IACT
GLYCINEInactive
Code: TE7660XO1C
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT

adalimumab-aqvh

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70114-220
Application NumberBLA761216
Product Classification
M
Marketing Category
C73585
G
Generic Name
adalimumab-aqvh
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateFebruary 28, 2023
FDA Product Classification

INGREDIENTS (7)

ADALIMUMABActive
Quantity: 40 mg in 0.8 mL
Code: FYS6T7F842
Classification: ACTIB
HISTIDINEInactive
Code: 4QD397987E
Classification: IACT
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATEInactive
Code: X573657P6P
Classification: IACT
GLYCINEInactive
Code: TE7660XO1C
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

YUSIMRY - FDA Drug Approval Details